Roger Day
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Biostatistics Biology, Epidemiology, StatisticsGoogle:
"Roger Day"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Casablanca Y, Mieznikowski J, Day R, et al. (2014) Molecular profiling of tumors from stage I versus stage III/IV cancer patients: A prediction signature for metastasis in Gynecologic Oncology Group 8024 Gynecologic Oncology. 133: 6 |
| Risinger JI, Allard J, Chandran U, et al. (2013) Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion. Frontiers in Oncology. 3: 139 |
| Wang M, Day R. (2009) Adaptive Bayesian design for phase I dose-finding trials using a joint model of response and toxicity. Journal of Biopharmaceutical Statistics. 20: 125-144 |
| Ramanathan RK, Lee KM, McKolanis J, et al. (2005) Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer. Cancer Immunology, Immunotherapy : Cii. 54: 254-64 |
| Ramanathan RK, Hwang JJ, Zamboni WC, et al. (2004) Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trial. Cancer Investigation. 22: 858-65 |
| Shackney SE, Smith CA, Pollice A, et al. (2004) Intracellular Patterns of Her-2/neu, ras, and Ploidy Abnormalities in Primary Human Breast Cancers Predict Postoperative Clinical Disease-Free Survival Clinical Cancer Research. 10: 3042-3052 |
| Welsh C, Day R, McGurk C, et al. (2004) Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. International Journal of Cancer. 110: 352-61 |
| Ramalingam S, Belani CP, Day R, et al. (2004) Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 15: 247-51 |
| Reichert TE, Scheuer C, Day R, et al. (2001) The number of intratumoral dendritic cells and ζ-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma Cancer. 91: 2136-2147 |
| Trump DL, Smith DC, Stiff D, et al. (1997) A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis. Cancer Chemotherapy and Pharmacology. 39: 349-56 |